RAP2A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.539700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.110100E-02
Normal-vs-Stage2
6.444100E-02
Normal-vs-Stage3
3.675000E-03
Normal-vs-Stage4
2.446800E-01
Stage1-vs-Stage2
9.542400E-01
Stage1-vs-Stage3
4.453800E-02
Stage1-vs-Stage4
4.905400E-01
Stage2-vs-Stage3
1.003400E-01
Stage2-vs-Stage4
4.887200E-01
Stage3-vs-Stage4
3.500500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.374200E-02
Normal-vs-AfricanAmerican
2.899600E-01
Normal-vs-Asian
2.265700E-02
Caucasian-vs-AfricanAmerican
4.635600E-01
Caucasian-vs-Asian
1.316410E-01
AfricanAmerican-vs-Asian
1.324400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.788200E-02
Normal-vs-Female
9.508400E-02
Male-vs-Female
7.883400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.654000E-02
Normal-vs-Age(41-60Yrs)
2.281200E-01
Normal-vs-Age(61-80Yrs)
5.658200E-02
Normal-vs-Age(81-100Yrs)
3.058200E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.991200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.930600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.658400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.199900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.857800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.329000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.155600E-02
Normal-vs-Daily Drinker
8.760000E-03
Normal-vs-Weekly Drinker
4.628400E-02
Normal-vs-Occasional Drinker
2.152000E-01
Normal-vs-Social Drinker
6.099000E-01
Non Drinker-vs-Daily Drinker
5.375600E-01
Non Drinker-vs-Weekly Drinker
6.402800E-01
Non Drinker-vs-Occasional Drinker
3.081600E-01
Non Drinker-vs-Social Drinker
1.232600E-01
Daily Drinker-vs-Weekly Drinker
3.268600E-01
Daily Drinker-vs-Occasional Drinker
1.603840E-01
Daily Drinker-vs-Social Drinker
7.042000E-02
Weekly Drinker-vs-Occasional Drinker
6.363200E-01
Weekly Drinker-vs-Social Drinker
2.225200E-01
Occasional Drinker-vs-Social Drinker
4.044600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.015200E-01
Normal-vs-Grade 2
8.690000E-01
Normal-vs-Grade 3
8.920400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.748600E-01
Grade 1-vs-Grade 3
6.964800E-01
Grade 1-vs-Grade 4
7.015200E-01
Grade 2-vs-Grade 3
6.904000E-01
Grade 2-vs-Grade 4
8.690000E-01
Grade 3-vs-Grade 4
8.920400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.580500E-02
Normal-vs-NonDiabetic
5.945800E-02
Diabetic-vs-NonDiabetic
7.279200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.197500E-03
Normal-vs-NoPancreatitis
9.506200E-02
Pancreatitis-vs-NoPancreatitis
1.095990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.979000E-01
Normal-vs-N1
5.415800E-02
N0-vs-N1
7.159400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.160400E-02
Normal-vs-TP53-NonMutant
1.536420E-01
TP53-Mutant-vs-TP53-NonMutant
2.429400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
